Nanobiotechnology in Diagnosis, Drug Delivery and Treatment. Группа авторов
Чтение книги онлайн.
Читать онлайн книгу Nanobiotechnology in Diagnosis, Drug Delivery and Treatment - Группа авторов страница 36
24 Ekladious, I., Liu, R., Varongchayakul, N. et al. (2018). Reinforcement of polymeric nanoassemblies for ultra‐high drug loadings, modulation of stiffness and release kinetics, and sustained therapeutic efficacy. Nanoscale 10: 8360–8366.
25 Ekladious, I., Colson, Y.L., and Grinstaff, M.W. (2019). Polymer–drug conjugate therapeutics: advances, insights and prospects. Nature Reviews Drug Discovery 18: 273–294.
26 Fay, F., McLaughlin, K.M., Small, D.M. et al. (2011). Conatumumab (AMG 655) coated nanoparticles for targeted proapoptotic drug delivery. Biomaterials 32: 8645–8653.
27 Fortina, P., Kricka, L.J., Graves, D.J. et al. (2007). Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Trends in Biotechnology 25: 145–152.
28 Gao, W., Thamphiwatana, S., Angsantikul, P., and Zhang, L. (2014). Nanoparticle approaches against bacterial infections. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 6: 532–547.
29 Gatoo, M.A., Naseem, S., Arfat, M.Y. et al. (2014). Physicochemical properties of nanomaterials: implication in associated toxic manifestations. BioMed Research International 2014: 1–8.
30 Gaur, A., Midha, A., and Bhatia, A.L. (2008). Significance of nanotechnology in medical sciences. Asian Journal of Pharmaceutics 2008: 80–85.
31 Gholami, Y.H. and Engel, A. (2018). Theranostic nanoplatforms for treatment and diagnosis of rectal and colon cancer: a brief review. Mini‐invasive Surgery 2 (44): 1–9.
32 Giau, V.V., An, S.S.A., and Hulme, J. (2019). Recent advances in the treatment of pathogenic infections using antibiotics and nano‐drug delivery vehicles. Drug Design, Development and Therapy 13: 327–343.
33 Greco, F. and Vicent, M.J. (2009). Combination therapy: opportunities and challenges for polymer‐drug conjugates as anticancer nanomedicines. Advanced Drug Delivery Reviews 61: 1203–1213.
34 Greish, K. (2007). Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. Journal of Drug Targeting 15: 457–464.
35 Gryparis, E.C., Hatziapostolou, M., Papadimitriou, E., and Avgoustakis, K. (2007). Anticancer activity of cisplatin‐loaded PLGA‐mPEG nanoparticles on LNCaP prostate cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 67: 1–8.
36 Gulbake, A., Jain, A., Jain, A. et al. (2016). Insight to drug delivery aspects for colorectal cancer. World Journal of Gastroenterology 22: 582–599.
37 He, H., Lu, Y., Qia, J. et al. (2019). Adapting liposomes for oral drug delivery. Acta Pharmaceutica Sinica B 9: 36–48.
38 Hoet, P., Bruske‐Hohlfeld, I., and Salata, O. (2004). Nanoparticles‐known and unknown health risks. Journal of Nanobiotechnology 2: 1–15.
39 Hong, R.L., Huang, C.J., Tseng, Y.L. et al. (1999). Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C‐26 tumor‐bearing mice: is surface coating with polyethylene glycol beneficial? Clinical Cancer Research 5: 3645–3652.
40 Howard, M.D., Jay, M., Dziubla, T.D., and Lu, X. (2008). PEGylation of nanocarrier drug delivery systems: state of the art. Journal of Biomedical Nanotechnology 4: 133–148.
41 Huynh, N.T., Passirani, C., Saulnier, P., and Benoit, J.P. (2009). Lipid nanocapsules: a new platform for nanomedicine. International Journal of Pharmaceutics 379: 201–209.
42 Jeevanandam, J., Barhoum, A., Chan, J.S. et al. (2018). Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein Journal of Nanotechnology 9: 1050–1074.
43 Jha, A.K., Goenka, M.K., Nijhawan, S. et al. (2012). Nanotechnology in gastrointestinal endoscopy: a primer. Journal of Digestive Endoscopy 3: S77–S80.
44 Kaasgaard, T., Mouritsen, O.G., and Jørgensen, K. (2001). Screening effect of PEG on avidin binding to liposome surface receptors. International Journal of Pharmaceutics 214: 63–65.
45 Keum, N. and Giovannucci, E. (2019). Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nature Reviews Gastroenterology & Hepatology https://doi.org/10.1038/s41575‐019‐0189‐8.
46 Kong, S.H., Noh, Y.W., Suh, Y.S. et al. (2015). Evaluation of the novel near‐infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/gamma‐glutamic acid complex for sentinel lymph node navigation surgery in large animal models. Gastric Cancer 18: 55–64.
47 Kovacevic, A., Savic, S., Vuleta, G. et al. (2011). Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure. International Journal of Pharmaceutics 406: 163–172.
48 Kumar, P.S., Datta, M.S., Kumar, D.M. et al. (2016). Potential application of dendrimers in drug delivery: a concise review and update. Journal of Drug Delivery and Therapeutics 6: 71–88.
49 Lacy, B.E., Mearin, F., Chang, L. et al. (2016). Bowel disorders. Gastroenterology 150: 1393–1407.
50 Laroui, H., Wilson, D.S., Dalmasso, G. et al. (2011). Nanomedicine in GI. American Journal of Physiology ‐ Gastrointestinal and Liver Physiology 300: G371–G383.
51 Laroui, H., Rakhya, P., Xiao, B. et al. (2013). Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders. Digestive and Liver Disease 45: 995–1002.
52 Lee, L.J. (2006). Polymer nano‐engineering for biomedical applications. Annals of Biomedical Engineering 34: 75–88.
53 Lopes, D., Nunes, C., Martins, M.C. et al. (2014). Eradication of Helicobacter pylori: past, present and future. Journal of Controlled Release 189: 169–186.
54 Lopes, D., Nunes, C., Martins, M.C.L. et al. (2015). Targeting strategies for the treatment of Helicobacter pylori infections. In: Nano Based Drug Delivery (ed. J. Naik), 339–366. Zagreb, Croatia: IAPC Publishing.
55 Lopes‐de‐Campos, D., Pinto, R.M., Lima, S.A. et al. (2019). Delivering amoxicillin at the infection site – a rational design through lipid nanoparticles. International Journal of Nanomedicine 14: 2781–2795.
56 Lovrić, J., Bazzi, H.S., Cuie, Y. et al. (2005). Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. Journal of Molecular Medicine 83: 377–385.
57 Lyberopoulou, A., Efstathopoulos, E.P., and Gazouli, M. (2016). Nanotechnology‐based rapid diagnostic tests. In: Proof and Concepts in Rapid Diagnostic Tests and Technologies (ed. K.S. Saxena), 89–105. London: IntechOpen.
58 Maeda, H., Wu, J., Sawa, T. et al. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release 65: 271–284.
59 Martinez‐Carmona, M., Gunko, Y.K., and Vallet‐Regi, M. (2018). Mesoporous silica materials as drug delivery: the nightmare of bacterial infection. Pharmaceutics 10 (279): 1–29.
60 Matea, C.T., Mocan, T., Tabaran, F. et al. (2017). Quantum dots in imaging, drug delivery and sensor applications. International Journal of Nanomedicine